Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT03562273

GammaPod Registry and Quality of Life Nomogram

Sponsor: University of Maryland, Baltimore

View on ClinicalTrials.gov

Summary

This study is a prospective, single arm study (registry) summarizing patient-level adverse-event and tumor outcomes as well as a number of feasibility and dosimetric characteristics of delivering a single-fraction boost with the GammaPod.

Official title: Tumor Bed Boost Using a Breast Specific Radiosurgery Device, The GammaPodTM: Registry Study and Evaluation of Quality of Life With Development of Sizing Nomogram

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

160

Start Date

2019-01-03

Completion Date

2030-12

Last Updated

2026-02-20

Healthy Volunteers

No

Interventions

RADIATION

Quality Of Life Sizing Nomogram

If the participant meets the eligibility criteria of the study, and participant chooses to take part, they will receive the tumor bed boost in 8 Gy in 1 fraction just prior to starting whole breast radiation after joining the study. Treatment to the whole breast will begin within 7-8 days from the TB boost (GammaPodTM) treatment. The radiation therapy will take approximately 6 weeks to complete. Follow-up visits specifically for this study will continue for one year, although the physician will continue to follow as part of routine care.

Locations (4)

Upper Chesapeake Health

Bel Air, Maryland, United States

Central Maryland Oncology Center

Columbia, Maryland, United States

Baltimore Washington Medical Center

Glen Burnie, Maryland, United States

UTSouthwestern

Dallas, Texas, United States